Biohaven Pharma: Q4 Earnings Insights

 

Biohaven Pharma Hldgs BHVN reported its Q4 earnings results on Friday, February 25, 2022 at 07:30 AM.

Here's what investors need to know about the announcement.

Also check this: Insiders Buy Around $98M Of 3 Stocks

Earnings

Biohaven Pharma Hldgs missed estimated earnings by 13.73%, reporting an EPS of $-2.32 versus an estimate of $-2.04.

Revenue was up $154.90 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.49 which was followed by a 1.47% drop in the share price the next day.

Here's a look at Biohaven Pharma Hldgs's past performance:

 

Quarter Q3 2021 Q2 2021 Q1 2021 Q4 2020
EPS Estimate -2.40 -2.74 -2.82 -2.97
EPS Actual -1.91 -2.62 -2.97 -2.69
Revenue Estimate 128.40M 78.13M 40.63M 28.23M
Revenue Actual 135.74M 92.93M 43.82M 35.11M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!